title: Medicinal prevention of pre-diabetes--no purpose?
authors.affiliation: Centre for Clinical Studies, Bergen, Norway.
authors.forename: Erik Snorre
authors.initials: ES
authors.lastname: Øfjord
authors.forename: Arne
authors.initials: A
authors.lastname: Skag
authors.forename: Steinar
authors.initials: S
authors.lastname: Helberg
authors.forename: Dagfinn
authors.initials: D
authors.lastname: Aarskog
authors.forename: Knut
authors.initials: K
authors.lastname: Risberg
authors.forename: Trine
authors.initials: T
authors.lastname: Jacobsen
authors.forename: Samuel
authors.initials: S
authors.lastname: Nasrala
authors.forename: Sjur
authors.initials: S
authors.lastname: Bakken
authors.forename: Unni
authors.initials: U
authors.lastname: Syversen
authors.forename: Trond
authors.initials: T
authors.lastname: Jenssen
mesh_terms: D047228:Angiotensin II Type 1 Receptor Blockers / Q000627:therapeutic use; D000959:Antihypertensive Agents / Q000627:therapeutic use; D003924:Diabetes Mellitus, Type 2 / Q000097:blood / Q000517:prevention & control*; D005951:Glucose Tolerance Test; D006801:Humans; D007004:Hypoglycemic Agents / Q000627:therapeutic use*; D016896:Treatment Outcome
chemical_list: D047228:Angiotensin II Type 1 Receptor Blockers; D000959:Antihypertensive Agents; D007004:Hypoglycemic Agents